Published in Mol Cancer Ther on April 18, 2013
Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog (2015) 0.91
Metastatic melanoma cells evade immune detection by silencing STAT1. Int J Mol Sci (2015) 0.75
Human T cell leukemia virus type I tax-induced IκB-ζ modulates tax-dependent and tax-independent gene expression in T cells. Neoplasia (2013) 0.75
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature (2011) 2.96
Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One (2010) 2.08
HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem (2009) 1.85
Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene (2004) 1.83
Head and neck cancer: past, present and future. Expert Rev Anticancer Ther (2006) 1.63
UVB-induced melanocyte proliferation in neonatal mice driven by CCR2-independent recruitment of Ly6c(low)MHCII(hi) macrophages. J Invest Dermatol (2013) 1.57
Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun (2007) 1.57
Novel markers for poor prognosis in head and neck cancer. Int J Cancer (2005) 1.48
Microarrays and epidemiology: not the beginning of the end but the end of the beginning... Cancer Epidemiol Biomarkers Prev (2007) 1.47
Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res (2004) 1.46
Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J Biol Chem (2002) 1.26
NFIA controls telencephalic progenitor cell differentiation through repression of the Notch effector Hes1. J Neurosci (2010) 1.24
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation. Pigment Cell Melanoma Res (2010) 1.21
Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope (2005) 1.21
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis (2013) 1.19
Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett (2006) 1.16
Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II. J Biol Chem (2010) 1.16
Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One (2011) 1.11
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev (2012) 1.10
Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur J Immunol (2011) 1.10
Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion (2012) 1.10
Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res (2009) 1.09
Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr (2007) 1.08
Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. Mol Aspects Med (2007) 1.07
Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms. Cancer Metastasis Rev (2012) 1.06
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett (2010) 1.04
Anticancer drugs targeting the mitochondrial electron transport chain. Antioxid Redox Signal (2011) 1.04
H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res (2009) 1.04
Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res (2007) 1.04
Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway. Cancer Res (2006) 1.03
Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res (2010) 1.00
Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. Proc Natl Acad Sci U S A (2007) 1.00
Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma. Int J Cancer (2002) 0.97
Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg (2004) 0.97
Histopathological features of clinical perineural invasion of cutaneous squamous cell carcinoma of the head and neck and the potential implications for treatment. Head Neck (2013) 0.96
Influence of ageing, heat shock treatment and in vivo total antioxidant status on gene-expression profile and protein synthesis in human peripheral lymphocytes. Mech Ageing Dev (2003) 0.96
Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer. BMC Cancer (2009) 0.94
Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies. Pigment Cell Res (2003) 0.94
Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities. Infect Immun (2008) 0.93
A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression. Cancer Res (2007) 0.92
Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype. Oncotarget (2013) 0.92
Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner. Cancer Res (2011) 0.92
Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid. J Med Chem (2006) 0.92
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogenesis (2011) 0.91
Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence. Clin Exp Metastasis (2012) 0.91
Reactive oxygen species are generated by the respiratory complex II--evidence for lack of contribution of the reverse electron flow in complex I. FEBS J (2013) 0.91
The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cells. Invest New Drugs (2009) 0.89
Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy. Free Radic Biol Med (2011) 0.88
PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells. Int J Biochem Cell Biol (2008) 0.88
Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment. PLoS One (2013) 0.88
Isoflavonoid photoprotection in mouse and human skin is dependent on metallothionein. J Invest Dermatol (2006) 0.86
What is transforming growth factor-beta (TGF-beta)? Br J Plast Surg (2004) 0.86
Multimodal polymer nanoparticles with combined 19F magnetic resonance and optical detection for tunable, targeted, multimodal imaging in vivo. J Am Chem Soc (2014) 0.85
Antiproliferative and phenotype-transforming antitumor agents derived from cysteine. J Med Chem (2004) 0.84
Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer. Int J Cancer (2006) 0.84
Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells. Immunol Cell Biol (2003) 0.84
Invasion and metastasis markers in cancers. Br J Plast Surg (2005) 0.84
Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10. J Immunol (2014) 0.84
The effect of laser irradiation on proliferation of human breast carcinoma, melanoma, and immortalized mammary epithelial cells. Photomed Laser Surg (2010) 0.84
Surfactant protein expression in human skin: evidence and implications. J Invest Dermatol (2006) 0.83
Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF. Int J Cancer (2007) 0.83
Reduced alphaB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma. Otolaryngol Head Neck Surg (2010) 0.83
Inhibitory effects associated with use of modified Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter assays and implications for analysis of ISGs. J Interferon Cytokine Res (2005) 0.83
Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation. BMC Cancer (2010) 0.82
Effect of novel marine nutraceuticals on IL-1α-mediated TNF-α release from UVB-irradiated human melanocyte-derived cells. Oxid Med Cell Longev (2011) 0.81
alpha-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels. Apoptosis (2010) 0.81
Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma. Mol Carcinog (2013) 0.80
Serum omega-3 and omega-6 fatty acids and cutaneous p53 expression in an Australian population. Cancer Epidemiol Biomarkers Prev (2011) 0.80
Expression of p53 tumor suppressor protein in sun-exposed skin and associations with sunscreen use and time spent outdoors: a community-based study. Am J Epidemiol (2006) 0.79
The potential role of CD133 in immune surveillance and apoptosis: a mitochondrial connection? Antioxid Redox Signal (2011) 0.79
Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse model. Cancer Immunol Immunother (2015) 0.78
Neural cell adhesion molecule expression: no correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck. Head Neck (2009) 0.78
Pestalactams A-C: novel caprolactams from the endophytic fungus Pestalotiopsis sp. Org Biomol Chem (2010) 0.78
Future use of mitocans against tumour-initiating cells? Mol Nutr Food Res (2009) 0.77
Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue. Biochim Biophys Acta (2012) 0.77
Affinity of vitamin E analogues for the ubiquinone complex II site correlates with their toxicity to cancer cells. Mol Nutr Food Res (2011) 0.77
Induction of metallothionein in human skin by routine exposure to sunlight: evidence for a systemic response and enhanced induction at certain body sites. J Invest Dermatol (2003) 0.76
Mitocans, a class of emerging anti-cancer drugs. Mol Nutr Food Res (2009) 0.76
Human T cell leukemia virus type I tax-induced IκB-ζ modulates tax-dependent and tax-independent gene expression in T cells. Neoplasia (2013) 0.75
Caelestines A-D, brominated quinolinecarboxylic acids from the Australian ascidian Aplidium caelestis. J Nat Prod (2010) 0.75
Plasticity of melanoma in vivo: murine lesions resulting from Trp53, but not Cdk4 or Arf deregulation, display neural transdifferentiation. Pigment Cell Melanoma Res (2013) 0.75
The human genome and gene expression profiling. J Plast Reconstr Aesthet Surg (2006) 0.75